Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06280872
Other study ID # P2023/Neonat/PhyCordPrem
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 19, 2024
Est. completion date July 2026

Study information

Verified date March 2024
Source Queen Fabiola Children's University Hospital
Contact Anna AMORUSO
Phone +3224773250
Email anna.amoruso@hubruxelles.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Before birth, the baby's lungs are filled with fluid and babies do not use the lungs to breathe, as the oxygen comes from the placenta. As delivery approaches, the lungs begin to absorb the fluid. After vaginal delivery, the umbilical cord is clamped and cut after a delay that allows some of the blood in the umbilical cord and placenta to flow back into the baby. Meanwhile, as the baby breathes for the first time, the lungs fill with air and more fluid is pushed out. However, it does not always work out that way. A baby born prematurely may have breathing problems because of extra fluid staying in the lungs related to the immaturity of the lung structure. Thus, the baby must breathe quicker and harder to get enough oxygen enter into the lungs. The newborn is separated from the mother to provide emergency respiratory support. Although the baby is usually getting better within one or two days, the treatment requires close monitoring, breathing help, and nutritional help as the baby is too tired to suck and swallow milk. Sometimes, the baby cannot recover well and show greater trouble breathing needing intensive care. This further separates the mother and her baby. A possible mean to help the baby to adapt better after a premature birth while staying close to the mother is to delay cord clamping when efficient breathing is established, either spontaneously or after receiving breathing help at birth. In this study, we intend to test this procedure in moderate or late preterm infants and see whether the technique helps the baby to better adapt after birth and to better initiate a deep bond with the mother.


Description:

The successful transition from fetal to neonatal life is a major physiological challenge that requires the coordination of lung developmental processes, which culminate with the formation of a diffusible alveolar-capillary barrier, adequate pulmonary vasoreactivity, mature surfactant system, and clearance of lung fluid. During fetal life, gas exchange does not take place in fetal lungs but in the placenta. High pulmonary vascular resistance diverts blood flow to the left atrium through the foramen ovale and to the aorta via the ductus arteriosus. The placental circulation receives 30-50 % of the fetal cardiac output and is the major source of venous return to the fetal heart. Therefore, the umbilical venous return determines the preload for the left ventricle. Shortly before birth and during labor, the lungs undergo important transitional changes. The reabsorption of lung fluid within the airways is initiated during labor by adrenaline-induced activation of sodium channels. Uterine contractions during labor and the onset of inspiration after umbilical cord clamping generate a high transpulmonary pressure gradient leading to additional clearance of fluid from the airways into the surrounding tissue . Following the first breath and lung aeration, oxygen-induced vasodilation leads to a sudden rise in pulmonary blood flow and left atrial pressures, which closes the foramen ovale. Meanwhile, systemic vascular resistance increases above the level of pulmonary vascular resistance after placental removal, which reverses blood flow across the ductus arteriosus and induces ductal closure in response to high oxygen tension. Premature birth can impact the success of adaptation to extrauterine life. Moderately preterm and late preterm births represented 4.4% of singleton live births in the Brussels area in 2020. Although they may be close to term, the loss of the last 4 to 8 weeks of gestation is vital to their physiologic and metabolic maturity. Because of their physiologic and metabolic immaturity, they have higher morbidity and mortality rates compared with term infants (gestational age 37 weeks). Although they may look similar to full-term infants, especially for the late preterm, the gap in the last few weeks of gestation is critical for physiological and metabolic maturation. Moderate and late preterm infants are at higher risk than term infants for a number of neonatal complications. This includes respiratory distress requiring non invasive or invasive ventilation, transient tachypnea of the newborn, intraventricular hemorrhage, periventricular leukomalacia, bacterial sepsis, apnoea, hypoglycemia, temperature instability, jaundice and hyperbilirubinaemia, feeding difficulties, neonatal intensive care admission, and also death. By contrast with lung's full-term newborn, lung of the preterm newborn presents an inability to adapt to extra-uterine life. Lung development at this time of gestation is in the saccular stage. Because of this immature lung structure, it results in delayed intrapulmonary fluid absorption, surfactant deficiency and inefficient gas exchange leading to respiratory morbidities such as transient tachypnea of the newborn, respiratory distress syndrome, persistent pulmonary hypertension. In addition, synchronicity and breath control is also immature and leads to apnea. These newborns exhibit a higher risk of positive pressure ventilation resuscitation at birth, admission to the neonatal intensive care unit (NICU), and severe hypoxic respiratory failure requiring mechanical ventilation in the most severe cases. In addition to increased neonatal morbidity, moderate or late preterm birth can impact mother-infant relationship. After delivery, immediate skin-to-skin contact during the first minute after birth is the natural process recommended to support mother-infant bonding and promote early onset of breastfeeding. Despite efforts made to start skin-to-skin contact as early as possible after delivery, immediate contact is practically difficult to implement related to the need for respiratory support for most of these newborns with incomplete transition to extrauterine life. In our institution, the infant is usually separated from the mother after umbilical cord clamping to provide first care by a pediatrician before returning on the mother's chest or on the father/partner's chest depending on parental wishes and maternal well-being during the operation and only if the condition of the newborn allows it. The separation between the mother and her newborn can be further extended in the case of NICU admission for various and multiple reasons related to prematurity. The timing of umbilical cord clamping can profoundly affect the process of neonatal cardiorespiratory transition. Immediate cord clamping reduces the venous return to the heart, which transiently decreases heartbeats, cardiac output and cerebral blood flow before respiration initiates and pulmonary blood flow increases. Delayed cord clamping for longer than 60 seconds improves the transfusion of blood from the placenta to the newborn. Moreover, it can increase neonatal hemoglobin levels, improve long-term iron stores, and improve neurodevelopmental outcomes. Nevertheless, in both clinical research setting and daily practice, delayed cord clamping lasts rarely more than one minute during cesarean section. More recently, another approach, referred to as physiologically based cord clamping (PBCC), has been proposed to delay cord clamping up to 5 minutes after the onset of ventilation. PBCC allows to start lung aeration while on placental support and, therefore, promotes hemodynamic transition by increasing pulmonary blood flow and maintaining left ventricle preload. This strategy has been demonstrated efficient in preterm lambs and is feasible in very preterm infants, via the use of a purpose-designed resuscitation table that allows delayed cord clamping, maintenance of body temperature, and concomitant respiratory support where necessary. First experience has reported good parental acceptance of the procedure. Because PBCC has not been reported in moderate and late preterm infants, the present project aims to assess whether PBCC in moderate and late preterm infants would not be inferior to standard umbilical cord clamping with regards to adaptation to extrauterine life, respiratory morbidity, quality of mother-infant bonding, and maternal safety.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date July 2026
Est. primary completion date January 2026
Accepts healthy volunteers No
Gender All
Age group 32 Weeks to 36 Weeks
Eligibility Inclusion Criteria: Pregnant women followed-up in Brugmann University Hospital will be eligible to participate if: - The delivery takes place between 32 0/7 and 36 6/7 weeks of gestation - They carry singletons Exclusion Criteria: - Fetal anomalies including congenital malformations, anemia, and growth restriction with abnormal Dopplers. - Abnormal placentation such as placenta previa. - Signs of fetal distress necessitating an emergency cesarean section. - Maternal health issue including severe anemia (defined as hemoglobin level < 7 g/dL), preeclampsia, and bleeding disorders. - Maternal refusal of the use of blood products. - General anesthesia for cesarian section. - Planned cord blood banking. - Total language barrier without possibility of translation

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physiological Based Cord Clamping
see Arm Description
Differed Cord Clamping
see Arm Description

Locations

Country Name City State
Belgium CHU Brugmann Brussels
Belgium Hôpital Universitaire Des Enfants Reine Fabiola Brussels

Sponsors (4)

Lead Sponsor Collaborator
Queen Fabiola Children's University Hospital Ars Statistica, Fonds IRIS-Recherche, The Belgian Kids Fund

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of non-invasive or invasive respiratory support. from Birth to 28 days of life
Secondary Rate of neonatal mortality within 28 days of delivery
Secondary Rate of neonatal resuscitation Neonatal resuscitation is defined as the use of a T-piece resuscitator for continuous airway positive pressure or intermittent positive pressure (with or without oxygen supplementation). within first 10 minutes of life
Secondary Rate of neonatal respiratory morbidity Neonatal respiratory morbidity includes respiratory distress syndrome, transient tachypnea of the newborn, air leak syndrome, and respiratory distress syndrome. from Birth to 28 days of life
Secondary Number of admission to the NICU or special care baby unit within first 72 hours of life
Secondary Length of hospitalization Up to 8 weeks post delivery
Secondary Gestational age corrected at discharge Up to 8 weeks post delivery
Secondary Changes in physiological variables during neonatal transition physiological variables includes the timing of the first breath/cry, measurements of parameters during the first 10 minutes of life (i.e., preductal oxygen saturation by pulse oximetry, respiratory rate, heart rate, and temperature), umbilical cord venous hemoglobin and gases, as well as Apgar scores at 1, 5, and 10 minutes. Within first 10 minutes of life
Secondary Early neonatal parameters Early neonatal parameters includes body temperature (at 1, 2 and 3 hours of life) and body weight. within first 24 hours of life
Secondary Hemoglobin level in g/dl At 48 hours of life
Secondary Bilirubin level in mg/dl At 48 hours of life
Secondary Occurrence of Neonatal adverse events Adverse events include hypoglycemia (glycemia <47 mg/dl), sepsis (positive blood culture), intraventricular hemorrhage, and the need for phototherapy Within first 72hours of life
Secondary Biological markers of oxidative stress immediately after cord clamping
Secondary Maternal perioperative parameters Maternal perioperative parameters include total surgical time, intraoperative intravenous fluid volume, intraoperative blood loss, uterotonic administration up to 3 hours post delivery
Secondary Maternal postoperative hemoglobin level in g/dl At day 1 post delivery
Secondary Number of maternal adverse events Maternal adverse events include death, blood transfusion, postpartum hemorrhage, hysterectomy, admission in the Intensive Care Unit, wound seroma, and wound cellulitis within first 2 weeks after delivery
Secondary Maternal-infant bonding Parameters of mother-infant bonding include breastfeeding (Yes/No) At 2 weeks of life
Secondary Maternal-infant bonding Parameters of mother-infant bonding include maternal depression measured by the Edinburgh Postnatal Depression Scale (EPDS) - score min = 0, score max = 30, higher score = worse outcome. At 2 weeks of life
Secondary Maternal-infant bonding Parameters of mother-infant bonding include maternal depression measured by the Maternal Infant Bonding Scale (MIBS) - score min = 0, score max = 24, higher score = worse outcome At 2 weeks of life
Secondary Rate of Maternal-infant bonding Parameters of mother-infant bonding include breastfeeding (Yes/No) At one month of life
Secondary Rate of Maternal-infant bonding Parameters of mother-infant bonding include maternal depression measured by the Edinburgh Postnatal Depression Scale (EPDS) - score min = 0, score max = 30, higher score = worse outcome. At one month of life
Secondary Rate of Maternal-infant bonding Parameters of mother-infant bonding include maternal depression measured the Maternal Infant Bonding Scale (MIBS) - score min = 0, score max = 24, higher score = worse outcome At one month of life
Secondary Maternal-infant bonding Brazelton Neonatal Behavioral Assessment Scale (NBAS) - score min = 1, score max = 6, higher score = better outcome At 42 weeks of corrected age
Secondary Parental satisfaction survey At 42 weeks of corrected age
Secondary Child development assessment The child development assessment is done using the Bayley scale IV - score min = 1 , score max = 19, higher score = better outcome At 6 months of corrected age
Secondary Success of PBCC measured by the percentage of neonates in whom the procedure will be achieved without issue, identification of failed PBCC, and duration of stabilization with PBCC (defined as spontaneous breathing, heart rate (HR) >100 bpm, oxygen saturation by pulse oximetry (SpO2 ) = 85% with inspired oxygen fraction < 0.4). within first 10 minutes of life
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A